1-20 of 21
David R Matthews
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes—2016. Diabetes Care 2016;39(Suppl. 1):S52–S59

William H. Herman, Rita R. Kalyani, Deborah J. Wexler, David R. Matthews, Silvio E. Inzucchi
Journal: Diabetes Care
Diabetes Care 2016;39(6):e88–e89
https://doi.org/10.2337/dci16-0003
Published: 13 May 2016
View article titled, Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In <em>Standards of Medical Care in Diabetes—2016</em>. Diabetes Care 2016;39(Suppl. 1):S52–S59
Open the PDF for Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In <em>Standards of Medical Care in Diabetes—2016</em>. Diabetes Care 2016;39(Suppl. 1):S52–S59 in another window
Journal Articles

Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140–149

Silvio E. Inzucchi, David R. Matthews
Journal: Diabetes Care
Diabetes Care 2015;38(8):e128–e129
https://doi.org/10.2337/dc15-0812
Published: 14 July 2015
View article titled, Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140–149
Open the PDF for Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140–149 in another window
Journal Articles

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L. Peters, Apostolos Tsapas, Richard Wender, David R. Matthews
Journal: Diabetes Care
Diabetes Care 2015;38(1):140–149
https://doi.org/10.2337/dc14-2441
Published: 13 December 2014
View article titled, Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Open the PDF for Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes in another window
Includes: Supplementary data
Journal Articles

Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2. Diabetes Care 2013;36: 2324–2330

Nathan R. Hill, Jonathan C. Levy, David R. Matthews
Journal: Diabetes Care
Diabetes Care 2014;37(9):2660
https://doi.org/10.2337/dc14-er09a
Published: 07 August 2014
View article titled, Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2. Diabetes Care 2013;36: 2324–2330
Open the PDF for Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2. Diabetes Care 2013;36: 2324–2330 in another window
Journal Articles

Cyclical Variation in HbA1c Values During the Year: Clinical and Research Implications

Nathan R. Hill, PHD, Catherine J. Peters, MD, Rebecca J. Thompson, MSC, David R. Matthews, DPhil, Peter C. Hindmarsh, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):e175–e176
https://doi.org/10.2337/dc13-1247
Published: 14 September 2013
View article titled, Cyclical Variation in HbA<sub>1c</sub> Values During the Year: Clinical and Research Implications
Open the PDF for Cyclical Variation in HbA<sub>1c</sub> Values During the Year: Clinical and Research Implications in another window
Journal Articles

Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2

Nathan R. Hill, DPHIL (OXON), Jonathan C. Levy, FRCP, David R. Matthews, DPHIL (OXON)
Journal: Diabetes Care
Diabetes Care 2013;36(8):2324–2330
https://doi.org/10.2337/dc12-0607
Published: 11 July 2013
View article titled, Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2
Open the PDF for Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2 in another window
Journal Articles

Monitoring of Individual Needs in Diabetes (MIND)-2: Follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study

Frank J. Snoek, PHD, Nancy Y.A. Kersch, MSC, Ebbe Eldrup, MD, Ilana Harman-Boehm, MD, Norbert Hermanns, PHD, Andrzej Kokoszka, MD, David R. Matthews, MD, Brian E. McGuire, PHD, Mirjana Pibernik-Okanović, PHD, Joelle Singer, MD, Maartje de Wit, PHD, Søren E. Skovlund, MSC
Journal: Diabetes Care
Diabetes Care 2012;35(11):2128–2132
https://doi.org/10.2337/dc11-1326
Published: 13 October 2012
View article titled, Monitoring of Individual Needs in Diabetes (MIND)-2: <subtitle>Follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study</subtitle>
Open the PDF for Monitoring of Individual Needs in Diabetes (MIND)-2: <subtitle>Follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study</subtitle> in another window
Journal Articles

Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379

David R. Matthews, MA, DPHIL, BM, BCH, FRCP, Silvio E. Inzucchi, MD, for the ADA/EASD Position Statement Group
Journal: Diabetes Care
Diabetes Care 2012;35(10):e72–e73
https://doi.org/10.2337/dc12-1184
Published: 11 September 2012
View article titled, Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
Open the PDF for Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 in another window
Journal Articles

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Silvio E. Inzucchi, MD, Richard M. Bergenstal, MD, John B. Buse, MD, Michaela Diamant, MD, Ele Ferrannini, MD, Michael Nauck, MD, Anne L. Peters, MD, Apostolos Tsapas, MD, Richard Wender, MD, David R. Matthews, MD
Journal: Diabetes Care
Diabetes Care 2012;35(6):1364–1379
https://doi.org/10.2337/dc12-0413
Published: 11 May 2012
View article titled, Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: <subtitle>Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)</subtitle>
Open the PDF for Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: <subtitle>Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)</subtitle> in another window
Includes: Supplementary data
Journal Articles

Monitoring of Individual Needs in Diabetes (MIND): Baseline Data From the Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) MIND Study

Frank J. Snoek, PHD, Nancy Y.A. Kersch, MSC, Ebbe Eldrup, MD, Ilana Harman-Boehm, MD, Norbert Hermanns, PHD, Andrzej Kokoszka, MD, David R. Matthews, MD, Brian E. McGuire, PHD, Mirjana Pibernik-OkanoviĆ, PHD, Joelle Singer, MD, Maartje de Wit, PHD, Søren E. Skovlund, MSC
Journal: Diabetes Care
Diabetes Care 2011;34(3):601–603
https://doi.org/10.2337/dc10-1552
Published: 17 February 2011
View article titled, Monitoring of Individual Needs in Diabetes (MIND): Baseline Data From the Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) MIND Study
Open the PDF for Monitoring of Individual Needs in Diabetes (MIND): Baseline Data From the Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) MIND Study in another window
Journal Articles

Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Bo Ahrén, MD, PHD, James E. Foley, PHD, Ele Ferrannini, MD, David R. Matthews, MD, Bernard Zinman, MD, Sylvie Dejager, MD, PHD, Vivian A. Fonseca, MD, FRCP
Journal: Diabetes Care
Diabetes Care 2010;33(4):730–732
https://doi.org/10.2337/dc09-1867
Published: 12 January 2010
View article titled, Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
Open the PDF for Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy in another window
Journal Articles

Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis: A prospective cohort study

Stephen M.P. O'Riordan, MRCPI, MD, Peter Hindmarsh, MD, FRCPCH, Nathan R. Hill, DPHIL, MBCS, David R. Matthews, DPHIL, FRCP, Sherly George, MSC, Peter Greally, MD, FRCPI, Gerard Canny, MD, FRCPI, Dubhfeasa Slattery, PHD, FRCPI, Nuala Murphy, MD, FRCPI, Edna Roche, MD, FRCPI, Colm Costigan, FRCPI, Hilary Hoey, MD, FRCPI
Journal: Diabetes Care
Diabetes Care 2009;32(6):1020–1022
https://doi.org/10.2337/dc08-1925
Published: 11 March 2009
View article titled, Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis: <subtitle>A prospective cohort study</subtitle>
Open the PDF for Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis: <subtitle>A prospective cohort study</subtitle> in another window
Journal Articles

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study

Michael Nauck, MD, PHD, Anders Frid, MD, Kjeld Hermansen, MD, Nalini S. Shah, MD, Tsvetalina Tankova, MD, Ismail H. Mitha, MD, Milan Zdravkovic, MD, PHD, Maria Düring, PHD, David R. Matthews, MD, for the LEAD-2 Study Group
Journal: Diabetes Care
Diabetes Care 2009;32(1):84–90
https://doi.org/10.2337/dc08-1355
Published: 01 January 2009
View article titled, Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: <subtitle>The LEAD (Liraglutide Effect and Action in Diabetes)-2 study</subtitle>
Open the PDF for Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: <subtitle>The LEAD (Liraglutide Effect and Action in Diabetes)-2 study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Resistance to Insulin Therapy Among Patients and Providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study

Mark Peyrot, PHD, Richard R. Rubin, PHD, Torsten Lauritzen, MD, Soren E. Skovlund, MSC, Frank J. Snoek, PHD, David R. Matthews, MD, Rüdiger Landgraf, MD, Line Kleinebreil, on behalf of the International DAWN Advisory Panel
Journal: Diabetes Care
Diabetes Care 2005;28(11):2673–2679
https://doi.org/10.2337/diacare.28.11.2673
Published: 01 November 2005
View article titled, Resistance to Insulin Therapy Among Patients and Providers: <subtitle>Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study</subtitle>
Open the PDF for Resistance to Insulin Therapy Among Patients and Providers: <subtitle>Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study</subtitle> in another window
Journal Articles

Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211) : A 12-week, double-blind, randomized, controlled trial

Sten Madsbad, MD, DMSC, Ole Schmitz, MD, DMSC, Jonas Ranstam, PHD, Grethe Jakobsen, MSCPHARM, David R. Matthews, DPHIL, FRCP, on behalf of the NN2211-1310 International Study Group
Journal: Diabetes Care
Diabetes Care 2004;27(6):1335–1342
https://doi.org/10.2337/diacare.27.6.1335
Published: 01 June 2004
View article titled, Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211) : <subtitle>A 12-week, double-blind, randomized, controlled trial </subtitle>
Open the PDF for Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211) : <subtitle>A 12-week, double-blind, randomized, controlled trial </subtitle> in another window
Journal Articles

Use and Abuse of HOMA Modeling

Tara M. Wallace, MD, Jonathan C. Levy, MD, David R. Matthews, MD
Journal: Diabetes Care
Diabetes Care 2004;27(6):1487–1495
https://doi.org/10.2337/diacare.27.6.1487
Published: 01 June 2004
View article titled, Use and Abuse of HOMA Modeling
Open the PDF for Use and Abuse of HOMA Modeling in another window
Journal Articles

One-Year Glycemic Control With a Sulfonylurea Plus Pioglitazone Versus a Sulfonylurea Plus Metformin in Patients With Type 2 Diabetes

Markolf Hanefeld, MD, PHD, Paolo Brunetti, MD, Guntram H. Schernthaner, MD, David R. Matthews, FRCP, MA, Bernard H. Charbonnel, MD, on behalf of the QUARTET Study Group
Journal: Diabetes Care
Diabetes Care 2004;27(1):141–147
https://doi.org/10.2337/diacare.27.1.141
Published: 01 January 2004
View article titled, One-Year Glycemic Control With a Sulfonylurea Plus Pioglitazone Versus a Sulfonylurea Plus Metformin in Patients With Type 2 Diabetes
Open the PDF for One-Year Glycemic Control With a Sulfonylurea Plus Pioglitazone Versus a Sulfonylurea Plus Metformin in Patients With Type 2 Diabetes in another window
Journal Articles

Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes: UKPDS 66

Richard J. Stevens, PHD, Ruth L. Coleman, BSC, Amanda I. Adler, FRCP, Irene M. Stratton, MSC, David R. Matthews, FRCP, Rury R. Holman, FRCP
Journal: Diabetes Care
Diabetes Care 2004;27(1):201–207
https://doi.org/10.2337/diacare.27.1.201
Published: 01 January 2004
View article titled, Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes: <subtitle>UKPDS 66 </subtitle>
Open the PDF for Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes: <subtitle>UKPDS 66 </subtitle> in another window
Journal Articles

Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program

Jonathan C Levy, BSC, MD, David R Matthews, MD, DPHIL, Michel P Hermans, MD
Journal: Diabetes Care
Diabetes Care 1998;21(12):2191–2192
https://doi.org/10.2337/diacare.21.12.2191
Published: 01 December 1998
View article titled, Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Open the PDF for Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program in another window
Journal Articles

Evidence for a Role for Insulin and Growth Hormone in Overnight Regulation of 3-Hydroxybutyrate in Normal and Diabetic Adolescents

Julie A Edge, MRCP, Dorothy A Harris, FIMLS, Paula E Phillips, B Rani Pal, MRCP, David R Matthews, David B Dunger, MD
Journal: Diabetes Care
Diabetes Care 1993;16(7):1011–1018
https://doi.org/10.2337/diacare.16.7.1011
Published: 01 July 1993
View article titled, Evidence for a Role for Insulin and Growth Hormone in Overnight Regulation of 3-Hydroxybutyrate in Normal and Diabetic Adolescents
Open the PDF for Evidence for a Role for Insulin and Growth Hormone in Overnight Regulation of 3-Hydroxybutyrate in Normal and Diabetic Adolescents in another window